To assess the effectiveness of interventions aimed to increase retinal screening among people with diabetes.
Introduction

D
iabetic retinopathy is a highly specific microvascular complication of diabetes and the leading cause of blindness in the United States among adults aged 24 to 75 years. 1 The number of people with diabetic retinopathy and vision-threatening diabetic retinopathy currently is high (4.1 million and 899,000 people, respectively), and is expected to increase by 2020 to 7.2 million and 1.6 million, respectively, among the general U.S. population aged 40 years and older. 2 Blindness due to diabetes costs the U.S. about $500 million annually in healthcare and associated services. 3 The natural history of diabetic retinopathy is well defined and understood. Early detection and timely treatment are key strategies for reducing the burden associated with diabetic retinopathy and resulting visual impairment. Empirical evidence from clinical trials indicates that diabetic retinopathy can be prevented or delayed through adequate control of blood glucose and blood pressure levels 4, 5 and effectively treated when timely retinal photocoagulation treatment is performed. 6, 7 Because retinal screening is crucial for reaching the goal of early detection and timely treatment, medical organizations recommend regular retinal screening for preventing blindness related to diabetic retinopathy. The American Diabetes Association recommends an annual dilated eye examination beginning 5 years after diagnosis of type 1 diabetes and at the time of diagnosis of type 2 diabetes, unless patients are otherwise indicated to be at low risk for retinopathy by their eye care provider. 8 Other organizations that support regular retinal screening include the World Health Organization (WHO), 9 the National Committee for Quality Assurance, 10 the National Eye Institute (National Eye Health Education Program), 11 and the Centers for Disease Control and Prevention (National Diabetes Education Program). 12 The latter two organizations have developed awareness programs for the public and for healthcare providers to promote annual dilated eye examination.
Despite evidence supporting the effectiveness of periodic screening for diabetic retinopathy, 4 -7 screening rates consistently fall far below recommended levels. 1 One of the U.S. national health objectives for 2010 is to increase the proportion of people with diabetes screened annually for diabetic retinopathy to 75% from the level of 47% in 1998. 13 In 1999, the WHO, along with the International Agency for the Prevention of Blindness, launched Vision 2020: The Right to Sight initiative with the goal of eliminating avoidable blindness in the world by 2020. 9 A systematic review of the effectiveness of interventions to promote screening for diabetic retinopathy is a key foundational step to develop sound national strategies to improve the early detection and treatment of vision-threatening diabetic retinopathy.
A systematic review was conducted to assess the effect of interventions to increase the use of retinal screening among people with diabetes. The primary objective was to examine which interventions are effective. Secondary objectives were to explore (1) what characteristics of the diabetic population correlate with improved screening, (2) what characteristics of the provider delivering or associated with the intervention modify the effect of interventions on screening, and (3) what characteristics of the healthcare system modify the effect of interventions on screening.
Methods
Data Sources
A systematic review protocol was developed using the methods of the Cochrane Collaboration. 14 In consultation with a medical research librarian, search strategies were formulated using an iterative process that used medical subject headings and key search terms, including diabetic retinopathy, retinal disease, vision screening, and related terms (available from the authors on request). The following databases were searched for studies published between 1980 and May 2005: MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane Library, and Cochrane Controlled Trials Register (including DARE). In addition, the following journals (expected to have the highest relevance) were manually searched for relevant articles published from 1980 to May 2005: Diabetes Care, Ophthalmology, Archives of Ophthalmology, and Acta Ophthalmologica.
Systematic searches were performed for relevant reviews of interventions to promote screening for diabetic retinopathy. Reference lists of all included studies and relevant reviews were examined for additional citations. Authors of original studies were contacted when data were unclear or missing.
Study Selection and Data Extraction
A search was conducted for both published and unpublished studies in any language that used interventions to promote screening for diabetic retinopathy. The following types of study designs were included: randomized clinical trials (RCTs), controlled clinical trials, controlled before-and-after trials, interrupted time series, and pre-post studies. A sufficient number of RCTs and controlled clinical trials (quasirandomized studies) were sought for pooled estimates, but other types of comparative design studies would have been considered if a sufficient number of RCTs were not found.
Titles and abstracts were screened for studies that fulfilled the inclusion criteria, and the full text was retrieved for all relevant articles. One author reviewed each article for inclusion, and when there was uncertainty as to its inclusion, a second author reviewed the paper to achieve consensus. Data from included studies were abstracted by two reviewers (one conducted formal abstraction and another checked for accuracy) and all data were reviewed again by a third author.
Data abstracted included participant characteristics, treatment regimens for diabetes and other medical conditions, setting, mode of delivery of the intervention, intervention characteristics, and study designs. All interventions were classified on the basis of their target groups into one of three categories: (1) interventions focusing on patients or populations, (2) interventions focusing on providers or practices, and (3) interventions focusing on healthcare system infrastructure and processes. If an intervention focused on more than one target group, it was classified as a multifoci intervention.
The methods of the Cochrane Collaboration were followed and quality assessments were conducted for potential selection, attrition, and detection bias. 14 The quality of studies was assessed using (1) participant sampling method, (2) Jadad score (RCTs only), (3) randomization procedure (RCTs only), (4) allocation concealment (RCTs only), (5) attrition, (6) blinding, and (7) baseline comparability. Studies were not excluded on the basis of poor quality, but a sensitivity analysis was performed to compare results between studies with high versus low risk of bias if data were sufficient. A funnel plot method was used to test for publication bias of included studies.
Data Analysis and Synthesis
The objective of this review was to determine the effectiveness of interventions for a broad range of populations and settings. Recognizing the potential for bias from confounding and secular trends in studies without randomization, 15 when these studies were included, they were analyzed separately from RCTs. Potential sources of bias were identified, and how they might have affected results was determined.
Relative risk (RR) 16 was used as the primary measure of effect. For RCTs, the RR was calculated as the prevalence of retinopathy screening at follow-up among an intervention group divided by the prevalence at follow-up among a control group. For studies other than RCTs, the RR was calculated as the prevalence of retinopathy screening after intervention divided by the prevalence at baseline. 16 Clinical and methodologic diversities were assessed in order to determine if a meta-analysis was appropriate.
14 To test for statistical heterogeneity, the chi-square test 14 was used, stratifying by study 16 absolute levels of screening were reported also for the intervention and comparison groups.
Results
The results of computerized searches were depicted in Figure 1 . Hand searches did not yield additional studies. Forty-eight eligible studies with seven companion papers [65] [66] [67] [68] [69] [70] [71] were identified, including 12 RCTs, 18 46, 50, 53, 60 three in the United Kingdom, 26, 39, 42 three in Israel, 33, 49, 64 one in Saudi Arabia, 17 and a few in other developed countries. 19, 41, 43, 63 (See Table 1 .) The mean age of participants in the 28 studies reporting age was 60.2 years (unweighted, standard deviation [SD]ϭ12.7). Study populations were 53.6% female, on average (21 studies did not report the gender of participants). Most studies did not provide information related to race/ethnicity, and only two studies targeted black populations exclusively. 18, 21 Mean duration of diabetes was 9.4 years (SDϭ7.9) (20 studies). Nineteen studies provided information regarding diabetes treatment, [17] [18] [19] 21, 28, 29, 31, 38, 39, 41, 43, 44, 48, 49, 54, 59, 60, 63, 64 and insulin was the treatment most often used. 18, 19, 21, 28, 29, 31, 38, 41, 43, 44, 48, 49, 54, 60, 63, 64 The quality of the studies varied; in particular, randomization procedure and allocation concealment among RCTs were rarely reported, and a funnel plot suggested the possibility of publication bias. Attrition ranged from 0% to 14.9% among the seven studies reporting these data. 19, 28, 32, 39, 40, 43, 53 The leading sources of attrition were as follows: (1) moved out of the area, (2) death, (3) poor health, (4) loss of interest, and (5) transportation difficulties. Table 2 shows the intervention focus, the RRs, and absolute retinal screening rates for each study. Among RCTs, five studies focused on patients and population, 21, 35, 44, 56, 65 five studies focused on the healthcare system, 30, 39, 40, 52, 54 one study focused on both patients and providers, 32 and one study focused on both patients and the healthcare system. 53 Among studies with designs other than RCTs, 14 focused on the healthcare system infrastructure and processes, 17, 19, 24, 29, 36, [41] [42] [43] 49, 55, 57, 58, 60, 62 five on patients or population, 28, 34, 51, 63, 64 and four on provider and practice. 23, 37, 50, 59 Among the interventions with multiple foci, most studies focused on both patients and providers. 20, 22, [25] [26] [27] 31, 38, 46, 47 There was significant diversity among populations, settings, and interventions so that a meta-analysis within each intervention type was not justified. The tests for statistical heterogeneity (Q, pϽ0.0001) supported the assessment of diversity.
The three-group categorization of interventions reflected the major foci of the interventions. This categorization encompassed the main mechanisms through which interventions increased retinal screening. Patientfocused interventions included (1) increased awareness of diabetic retinopathy among people with diabetes, 18, 20, 25, 27, 38, 44, 51, 56, 63, 64 and (2) improved adherence to recommendations among patients. 22, 27, 47, 58 Providerfocused interventions included (1) improved adherence to recommendations among providers, 22, 27, 47, 50, 58, 59 (2) reduced negligence of practices, 25, 34, 51 and (3) improved flexibility of providers and practices. 28, 45, 61 System-focused interventions included (1) adequate access to health care, 18, 21, 39, 41, 43, 63 (2) improved availability of a healthcare delivery system, 17, 29, 49, 57 46 Lee (2000), 70 Harper (1998) 69 Patients or population, and provider and practice
Community-based screening program using letters, brochures, and education materials for GPs and patients.
Community-based program worked for both patients and providers and increased patient awareness and provider adherence to guideline. 2.01 (95% CIϭ1.48 -2.73). 21 Similar results were noted among the nonrandomized study designs, 28, 34, 51, 63, 64 the RR ranged from 1.12 (95% CIϭ1.02-1. 22) 63 to 1.80 (95% CIϭ1.59 -2.03). 64 Five RCTs focusing on the healthcare system infrastructure and processes also demonstrated that interventions increased screening significantly 30, 39, 40, 52, 54 ; the RR ranged from 1.12 (95% CIϭ1.03-1.22) 39 to 5.56 (95% CIϭ2. 19 -14.10) . 30 Most of the nonrandomized studies also demonstrated improvements 17, 19, 24, 36, 41, 43, 49, 55, 57, 58, 62 ; the RR ranged from 1.17 (95% CIϭ1.11-1.24) 43 to 5.46 (95% CIϭ5. 17-5.78 ). 19 No RCTs focused only on provider and practice. Three of four studies with designs other than RCTs demonstrated increased screening 23, 37, 50, 59 ; the RR ranged from 1.32 (95% CIϭ1. 16 53 Among studies with nonrandomized study designs and multiple foci, eight of nine that focused on both patients and providers demonstrated significantly increased screening 20, 22, [25] [26] [27] 31, 38, 46, 47 ; the RR ranged from 1.15 (95% CIϭ1.08 -1.23) 27 to 4.16 (95% CIϭ3. 10 -5.58) . 31 Three studies focusing on both provider and system demonstrated increased screening as well 33, 45, 48 ; the RR ranged from 1.19 (95% CIϭ1. 16 -1.23) 45 to 1.77 (95% CIϭ1.61-1.96). 33 One study that focused on all three-patients, providers, and systemalso increased screening (RR 1.63 [95% CIϭ1.45-1.83]). 61 In general, studies with non-RCT designs were conducted in more diverse populations and settings than RCTs.
As shown in Figure 2 , all RCTs with interventions focusing on the healthcare system significantly increased retinal screening. The highest increase in retinal screening was reflected by an RR of 5.56 (95% CIϭ2.19 -14.10). 30 Further, 11 out of 12 RCTs demonstrated that effects can be sustained for Ͼ1 year.
Some characteristics of diabetic populations and healthcare systems were found to be related to the effect of interventions. Interventions were less likely to reach the goal of increased screening if they were conducted in rural residences, 60 in a population consisting of a higher proportion of ethnic minorities, 29, 38 and in a large study population. 23, 56 By contrast, interventions were more likely to reach the goal if healthcare systems were equipped with computerized registration systems or databases. [22] [23] [24] [25] 26, 35, 47, 52, 55, 62 There was also evidence that interventions were more likely to succeed if they were involved in multidisciplinary collaboration and comprehensive multicomponent interventions. 24, 27, 56, 60, 62 
Discussion and Conclusion
Many of these studies showed significant improvements in retinal screening in intervention groups, suggesting that a variety of interventions can be effective. In all but one RCT 56 reviewed, interventions achieved statistically significant increases in retinal screening in the intervention group compared to the control group. Studies showed that the following interventions were effective: increasing patient and provider awareness of diabetic retinopathy, improving access to health care, introducing computer-based registration or reminder systems, collaboration among local organizations that provide retinal screening, and developing a community-based healthcare system. These interventions, like many other chronic care interventions, improved the screening for diabetic retinopathy in the health system settings at the community, organization, practice, and patient levels. These findings were also consistent with the mechanisms as a chronic care model demonstrated. 72 When all elements of the chronic care model, such as the community, the health system, self-management support, delivery system design, decision support, and clinical information systems, were combined, the combination could foster productive interactions between informed patients who took an active part in their care and providers with resources and expertise. 72 Awareness by patients and providers of the risk of diabetic retinopathy is crucial for successfully intervening to improve retinal screening use. Within this review, a "reminder" was the most frequently used intervention to promote the retinal screening, 18, 26, 34, 43, 46, 55, 63 and it was more effective if sent to both physicians and patients. 64 Furthermore, this approach could be applicable on a national level if health plans and physicians had a collaborative relationship. 47 Although a reminder can increase patients' awareness and improve their adherence to diabetic retinal screening recommendations, 27 one study found that sustaining the effect can be difficult. 56 Evidence also suggests that there is only small improvement in screening rates after the second reminder and no incremental improvement with additional reminders. 35 This ceiling effect may occur because people who are contemplating action are moved to action, while the remaining population is resistant to obtaining the desired services. One study suggests that further screening rate increases may require other approaches, such as education programs. 35 Register, review, and recall were found to be powerful components of interventions to improve rates of retinal screening. 32, 51, 52 These components also support administrative measures in quality improvement, because they provide an efficient mechanism for tracking and monitoring the successful delivery of health care. 32, 51, 52 The wide application of electronic medical record systems and electronic management systems 18, 23, 35, 41, 53, 54 have facilitated this implementation of these components, although a registry and a basic paper tracking mechanism can also be used. 23 A simple physician feedback tool with a paper checklist worked efficiently in one setting to improve the rate of retinal screening. 59 An increase in retinal screening depends not only on patients' adherence to diabetes care recommendations, but also on physicians' adherence to recommended guidelines for an annual examination. 18, 21 This review showed the importance of both patients and providers participation. Eight of nine studies with nonrandomized designs and multiple foci on both patients and providers demonstrated significantly increased screening. 20, 22, [25] [26] [27] 31, 38, 46, 47 The dual patient/physician approach fosters patients' participation in the process of their own medical care. Such participation can be less costly and less labor intensive. 22 Studies also showed that the effectiveness of education intervention depends to a great degree on such dual participation. 30, 50 Fostering patients' participation in their care, therefore, significantly improves the quality of care delivered to patients with diabetes, 31 and should be made the primary goal of strategies to promote retinal screening. 51 Diabetes management is a complex process, and studies demonstrated that multidisciplinary collaboration or comprehensive multicomponent interventions can achieve higher screening rates. 24, 27, 56, 60, 62 A multifaceted approach to improving diabetes management-increasing physicians awareness and knowledge on the one hand and improving their clinical performance by use of incentives on the other-was found to address the complexity of the diabetes treatment process. 45 Adequate access to health care is a primary determinant of success of interventions focusing on healthcare systems. This review revealed that the rate of retinal screening could be improved through improving access to primary care. 18, 20, 29, 38, 40, 45, 48, 49, 65 In the systematic review, the identified inadequate access included financial constraints, 20, 38, 65 cultural tensions, 18, 45 and maldistribution of the healthcare workforce or geographic components. 29, 48, 49 One study 66 found that for under-served ethnicminority populations, the lack of health insurance or healthcare availability hindered intervention to further increase recommended screening. Many communitybased organizations serving inner-city residents were strapped for resources. 66 A solution may be collaboration with community-based organizations. 66 Focusing an intervention on high-risk subgroups is a valid strategy for improving overall rates. 21 In an under-served inner-city area, structured prompting of community care-enabling general practitioners to structure diabetic care-was proven to be an efficient way to increase retinal screening. 39 Cultural factors such as language may also influence the effectiveness of an intervention. A culturally tailored approach in a community-based screening program played a role in promoting retinal screening. 46 This program provided patients with a brochure in both English and the main languages spoken within specific ethnic areas (e.g., in rural areas of the La Trobe and Coulburn Valleys, Australia). 46 Backlund et al. 19 reported that examining patients in a more familiar and reassuring environment within their own primary healthcare centers minimized barriers to access. In rural and ethnically diverse communities, use of telemedicine could bridge barriers to access, such as transportation. 30 A mobile diabetes clinic was used to improve access in a geographically spread-out population. 40, 48 A program of training, credentialing, and ongoing professional development for retinal practitioners was found to be effective in a remote rural area in which providers were scarce. 50 This review has several limitations. Heterogeneity among study designs, types of interventions, the length of follow-up, and the characteristics of participants made quantitative synthesis and between-study comparisons difficult. As mentioned previously, all studies were divided into three groups on the basis of their primary intervention foci. There was, however, considerable diversity of interventions within each of the three groups. For example, within the group focused on patients and populations, one study may have used an education program to promote patient awareness of retinal screening, while another study may have used reminders for patients. This diversity made syntheses difficult and precluded a quantitative synthesis. The characteristics of healthcare systems were variable; thus, specific interventions may be applicable to certain settings, regions, or countries. Publication bias (i.e., positive studies are more likely to get published than negative studies) likely exists, affecting the conclusions.
The findings of this systematic review demonstrated that by increasing patient awareness of diabetic retinopathy, improving the performance of providers and practices, and improving healthcare system infrastructure and processes, interventions can significantly improve screening rates for diabetic retinopathy. Further research should explore strategies for increasing retinal screening among diverse or disadvantaged populations and the economic efficiency of effective interventions in large community populations.
